H

Haemonetics Corp
D

HAE

85.570
USD
0.15
(0.18%)
Market Closed
Volume
15,831
EPS
3
Div Yield
-
P/E
36
Market Cap
4,297,658,011
Related Instruments
    ABT
    ABT
    0.850
    (0.74%)
    117.74 USD
    B
    BAX
    0.260
    (0.82%)
    31.970 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    SYK
    SYK
    6.90
    (1.80%)
    384.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: Haemonetics Corp

Sector: Healthcare
Industry: Medical Instruments & Supplies
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.